Blood Cancers Completed Phase 2 Trials for Hydrocortisone (DB00741)

Also known as: Blood Cancer

IndicationStatusPhase
DBCOND0048268 (Blood Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00185692Allogeneic Transplantation From Related Haploidentical DonorsTreatment